AR057933A1 - Composicion farmaceutica despigmentante que comprende n-(2-((3-(4- bromofenil)- 2- propenil ) amino) etil) -5- isoquinolinsulfonamida (h89) - Google Patents

Composicion farmaceutica despigmentante que comprende n-(2-((3-(4- bromofenil)- 2- propenil ) amino) etil) -5- isoquinolinsulfonamida (h89)

Info

Publication number
AR057933A1
AR057933A1 ARP060105185A ARP060105185A AR057933A1 AR 057933 A1 AR057933 A1 AR 057933A1 AR P060105185 A ARP060105185 A AR P060105185A AR P060105185 A ARP060105185 A AR P060105185A AR 057933 A1 AR057933 A1 AR 057933A1
Authority
AR
Argentina
Prior art keywords
isoquinolinsulfonamide
depigmenting
amino
pharmaceutical composition
bromofenil
Prior art date
Application number
ARP060105185A
Other languages
English (en)
Inventor
Corine Bertolotto
Robert Ballotti
Flavio Luciani
Mehdi Khaled
Original Assignee
Galderma Res & Dev
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Inst Nat Sante Rech Med filed Critical Galderma Res & Dev
Publication of AR057933A1 publication Critical patent/AR057933A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Composicion farmacéutica despigmentante que comprende una cantidad eficaz de N-[2-[[3-(4-bromofenil)-2-propenil]amino]etil]-5-isoquinolinsulfonamida (H89) en un soporte farmacéuticamente aceptable.
ARP060105185A 2005-11-25 2006-11-24 Composicion farmaceutica despigmentante que comprende n-(2-((3-(4- bromofenil)- 2- propenil ) amino) etil) -5- isoquinolinsulfonamida (h89) AR057933A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511977A FR2893841B1 (fr) 2005-11-25 2005-11-25 Composition pharmaceutique depigmentante comprenant du n-(2-((3-(4-bromophenyl)-2- propenyl)amino)ethyl)-5-isoquinolinesulfonamide(h89)

Publications (1)

Publication Number Publication Date
AR057933A1 true AR057933A1 (es) 2007-12-26

Family

ID=36934164

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105185A AR057933A1 (es) 2005-11-25 2006-11-24 Composicion farmaceutica despigmentante que comprende n-(2-((3-(4- bromofenil)- 2- propenil ) amino) etil) -5- isoquinolinsulfonamida (h89)

Country Status (3)

Country Link
AR (1) AR057933A1 (es)
FR (1) FR2893841B1 (es)
WO (1) WO2007060182A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112903657B (zh) * 2021-01-28 2022-06-24 中山大学 一种三聚氰胺和甲醛的表面增强拉曼光谱检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835252B1 (fr) * 2002-01-25 2005-08-05 Seppic Sa Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaicir la peau
US7256200B2 (en) * 2003-02-10 2007-08-14 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Method and composition for potentiating an oplate analgesic

Also Published As

Publication number Publication date
FR2893841B1 (fr) 2014-04-25
WO2007060182A1 (fr) 2007-05-31
FR2893841A1 (fr) 2007-06-01

Similar Documents

Publication Publication Date Title
NO2019005I1 (no) N-[2-(dietylamino)etyl]-5-[(Z)-(5-fluoro-2-okso-1,2-dihydro-3H-indol-3-yliden)metyl]-2,4-dimetyl-1H-pyrrol-3-karboksamid (sunitinib), samt farmasøytisk akseptable salter
CY2016042I2 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
RS51343B (sr) Nova kompozicija i njena upotreba
DK1478399T3 (da) Oral dosisform indeholdende en pde-4-inhibitor som en aktiv bestanddel og polyvinylpyrrolidone som excipiens
LU93093I2 (fr) Nécitumumab et ses dérivés pharmaceutiquement acceptables (portrazza)
CY1109523T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv
CY2015053I2 (el) Υδροξαμικα παραγωγα χρησιμα ως αναστολεις δεακετυλασης
IL225167A (en) Annotations (para-methoxy) phenyl-sulfonamide, n- (isobutyl), n - [(r2) - hydroxy- (r3) - benzyl-profile]
PE20081187A1 (es) Combinaciones de inhibidores de ang2 y vegf
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
DE60309433D1 (de) Pharmazeutische zusammensetzungen für protease-hemmer für hepatitis-c-virus
UY28330A1 (es) Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
DK2289514T3 (da) Pramipexol-doseringsform til anvendelse én gang dagligt
BRPI0507652A (pt) composições farmacêuticas compreendendo um derivado de benzoidiazepina e um inibidor da proeìna de fusão de rsv
WO2007139860A3 (en) Heterobicylic metalloprotease inhibitors
NO20041709L (no) N-substituerte pyrrolidinderivater som dipeptidyl peptidase IV inhibitorer
NO20050652L (no) Pyrrolidone derivater som maob inhibitorer
PE20061373A1 (es) Composicion farmaceutica que contiene 'n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamida
GEP20104878B (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
CL2007001689A1 (es) Formas cristalinas sustancialmente puras de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida; composicion farmaceutica, util para tratar una enfermedad que responde a una inhibicion de la actividad de cinasa de prot
ECSP088957A (es) Composición farmacéutica estable que contiene docetaxel y método para su fabricación
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
UY30403A1 (es) Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]fenil]-2e-2-propenamida

Legal Events

Date Code Title Description
FB Suspension of granting procedure